Thursday, May 07, 2020 Primary publication for IND226 Juergens RA, Hao D, Ellis PM, Tu D, Mates M, Kollmannsberger C, Bradbury PA, Tehfe M, Wheatley-Price P, Robinson A, Bebb G, Laskin J, Goffin J, Hilton J, Tomiak A, Hotte S, Goss GD, Brown-Walker P, Sun X, Tsao MS, Cabanero M, Gauthier I, Song X, Dennis PA, Seymour LK, Smoragiewicz M, Laurie SA. A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226. Lung Cancer 143: 1-11, 2020. https://www.sciencedirect.com/science/article/pii/S0169500220303135?via%3Dihub MA33 QoL journal article King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH, Chua BH, Phillips C, Bryant G, Westenberg H, Purohit OP-K, Ahern V, Graham P, Akra M, McArdle O, O'Brien P, Ludbrook J, Harvey J, Maduro JH, Gabelle-Flandin I, Kirkove C, Bedi C, Martin J, Vu T, Muanza T, Neal A, Courdi A, Thariat J, Rakovitch E, Daniels L, van Hezewijk M, Cwajna W, Roelstraete A, van Baardwijk A, Russel N, Koch A, Croke J, Locke I, Jeal P, Walker Q, Thuraisingham K, Chauduri A, Joseph D, Taylor M, Vanderkam S, Woo T, Tang J, Yassa M, Wai E, Hewitt S, Mahmood S, Gilmore J, Ofi B, Bahl A, Vujovic O, Yu E, Le D, Kong I, Nichol A, Bijker N, Delaney G, Feigen M, Lim A, Chao M, Latham M, Algurafi H, Tausch C, Khoo E, Leung S, Taylor K, Senthi S, Stevens A, Chaudhuri A, Cleator S, Brunt AM, Babington S, Christie D, Zwahlen D, Schratzenstaller U, Masson L, Storey N, Kumar E, Sherwin L, Weytjens R, Ravi S, Lawton P, Angell R, Round G, Allen A, Thotathil Z, Anthes M, Reuter C, Pettit L, Pettit L, Zissiadis Y, Elder C, Verbeek-de Kanter A, Lirette A, Plasswilm L, Spooner D, Hoar F, Mohamed I, Lossl K, Loo V, Richetti A, Evans T, Hennessy A, El-Mallah M, Skala M, Awad R, Germain I, Mitine C, Van Parijs H, Churn M, Walji N, Francis M, Stellamans K, Gruber G, Ivaldi G, Alhasso A, Kenny L, Tiver K, Griffin M, Lamoury G, Trovo M, Algufarfi H, Walji N, Lah M, Christie D, Alhasso A, Carruthers S, Papadatos G, Paardekooper G, Chaudhuri A, Persic M, Lavery B. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial (ONLINE). The Lancet Oncology 2020. https://www.sciencedirect.com/science/article/pii/S1470204520300851?via%3Dihub
